Ligandal
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
399 Sands Street Building 303 Ste 609, B...Phone Number
(650) 866-5212Website
www.ligandal.comRevenue
$5.2 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Ligandal
Ligandal is a biotechnology company focused on accelerating precision medicine through advanced targeting technology. Their platform delivers therapeutics to the exact molecular locations of disease, transforming treatments from symptom management to addressing root causes with atomic accuracy. Ligandal's innovative Peptide Direct Conjugate (PDC) technology enables targeted medicine delivery, making it possible to unlock cures previously thought impossible. The company aims to empower researchers and companies to target disease at its molecular roots, enhancing patient outcomes through precise and personalized therapeutic solutions.Explore more
Ligandal Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ligandal your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Ligandal is spiking on competitors!
Earning: See what the market has to say on Ligandal recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Ligandal
Funding: Get notified immidiatlly once Ligandal has new funding data
Click to see if Ligandal had a recent Job posting/layoffs
Ligandal, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Ligandal launches new products
Check if Ligandal has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Ligandal as Masked Content
Find 3 more new buyers
Compare Similar Companies to Ligandal
Compare insights from companies similar to Ligandal, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Ligandal
$5.2M
11-50
Private
<$5M
2013
TN
Tushar NuwalBusiness Corporate Development, Alliance Management & Commercial Strategy Head
Company Profile Activity
Activity Insights
Ligandal is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ligandal is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ligandal.
Ligandal financials insights
Gather financial insights about Ligandal, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$84K
Ligandal Tech Stack
A closer look at the technologies used by Ligandal
Ligandal News & Media
Ligandal Partners With Nanotronics to Solidify Optimization and Quality in Personalized Genomic Medicine Delivery Systems
NEW YORK--(BUSINESS WIRE)-- #ArtificialIntelligence--Ligandal Inc., a leader in personalized genomic medicine, biomaterials, and AI and Nanotronics, a developer of advanced intelligent inspection systems and production hardware for adaptive manufacturing, today announced a partnership to commercialize, develop, and provide next-generation technologies for gene therapy, peptide materials, nanomaterials, and characterization of biological technologies. Together, the two companies will implement fuGenetic Medicine will be the Solution to COVID-19, and Ligandal is...
Ligandal, one of the world’s leading genetic medicine companies, has modelled a synthetic peptide that could be an effective COVID-19 treatment and SARS-CoV-2 vaccine. Peptides are strings of amino... (PRWeb June 18, 2020) Read the full story at https://www.prweb.com/releases/genetic_medicine_will_be_the_solution_to_covid_19_and_ligandal_is_leading_the_way/prweb17198857.htmLigandal Proposes ‘Antidote’ to COVID-19 Using Robot-like Peptide Scaffolds
The company suggests its approach can actually help eliminate the virus from an already-infected host, while also bolstering the immune response.Ligandal Is Developing Potential Antidote And Vaccine To SARS-CoV-2
SAN FRANCISCO, April 14, 2020 /PRNewswire/ -- Biological engineering company Ligandal, Inc. is applying its unique peptide-based delivery technologies to develop a prospective antidote and vaccine for SARS-CoV-2 (the novel coronavirus) to be formulated and developed in response to the...
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ligandal
Sign Up For FreeTo access detailed company insights
Ligandal is a biotechnology company focused on accelerating precision medicine through advanced targeting technology. Their platform delivers therapeutics to the exact molecular locations of disease, transforming treatments from symptom management to addressing root causes with atomic accuracy. Ligandal's innovative Peptide Direct Conjugate (PDC) t... Read More
